DarioHealth Corp. Common Stock (DRIO)

Price$7.50

Value ScoreB

Growth ScoreD

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-45.27%

Price vs S&P 500 (4W)-3.96%

VGM Score42.97

Market Capitalization$54.84M

All Metrics

Book Value / Share (Quarterly)$8.55

P/TBV (Annual)1.48x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-6.85%

Cash Flow / Share (Quarterly)$-3.48

Price vs S&P 500 (YTD)-42.05%

Gross Margin (TTM)56.55%

Net Profit Margin (TTM)-192.23%

EPS (TTM)$-10.96

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-10.96

Revenue Growth (5Y)24.15%

EPS (Annual)$-10.47

ROI (Annual)-42.28%

Gross Margin (Annual)56.64%

Net Profit Margin (5Y Avg)-247.15%

Cash / Share (Quarterly)$2.74

Revenue Growth QoQ (YoY)-17.30%

ROA (Last FY)-37.90%

Revenue Growth TTM (YoY)-24.41%

EBITD / Share (TTM)$-7.49

ROE (5Y Avg)-78.10%

Operating Margin (TTM)-179.11%

Cash Flow / Share (Annual)$-3.78

P/B Ratio0.88x

P/B Ratio (Quarterly)0.94x

Net Income / Employee (Annual)$-260,700

EV / Revenue (TTM)3.10x

Net Interest Coverage (TTM)-16.68x

ROA (TTM)-37.08%

EPS Incl Extra (Annual)$-10.47

Current Ratio (Annual)3.76x

Quick Ratio (Quarterly)2.63x

3-Month Avg Trading Volume0.01M

52-Week Price Return-46.12%

Revenue / Employee (TTM)$132,400

Tangible BV / Share (Quarterly)$6.43

P/S Ratio (Annual)2.45x

Asset Turnover (Annual)0.20x

52-Week High$17.74

Operating Margin (5Y Avg)-261.04%

EPS Excl Extra (Annual)$-10.47

CapEx CAGR (5Y)3.42%

Tangible BV CAGR (5Y)48.48%

26-Week Price Return-37.34%

Quick Ratio (Annual)3.13x

13-Week Price Return-24.92%

Total Debt / Equity (Annual)0.45x

Current Ratio (Quarterly)3.07x

Enterprise Value$65.76M

Revenue / Share Growth (5Y)34.58%

Asset Turnover (TTM)0.19x

Book Value / Share Growth (5Y)23.17%

Revenue / Employee (Annual)$139,700

Inventory Turnover (Annual)2.14x

Pretax Margin (Annual)-186.10%

Cash / Share (Annual)$3.77

3-Month Return Std Dev70.40%

Gross Margin (5Y Avg)37.87%

Net Income / Employee (TTM)$-254,600

ROE (Last FY)-61.41%

Net Interest Coverage (Annual)-8.24x

EPS Basic Excl Extra (Annual)$-10.47

Receivables Turnover (TTM)7.09x

Total Debt / Equity (Quarterly)0.50x

EPS Incl Extra (TTM)$-10.96

Receivables Turnover (Annual)5.99x

ROI (TTM)-41.57%

P/S Ratio (TTM)2.59x

Pretax Margin (5Y Avg)-248.33%

Revenue / Share (Annual)$5.61

Tangible BV / Share (Annual)$7.53

Price vs S&P 500 (52W)-70.49%

Year-to-Date Return-34.09%

5-Day Price Return-2.60%

EPS Normalized (Annual)$-10.47

ROA (5Y Avg)-52.77%

Net Profit Margin (Annual)-186.56%

Month-to-Date Return-3.23%

Cash Flow / Share (TTM)$-2.02

EBITD / Share (Annual)$-10.09

Operating Margin (Annual)-181.12%

LT Debt / Equity (Annual)0.45x

ROI (5Y Avg)-60.23%

LT Debt / Equity (Quarterly)0.50x

EPS Basic Excl Extra (TTM)$-10.96

P/TBV (Quarterly)1.25x

P/B Ratio (Annual)1.13x

Inventory Turnover (TTM)2.09x

Pretax Margin (TTM)-191.57%

Book Value / Share (Annual)$9.84

Price vs S&P 500 (13W)-33.18%

Beta1.06x

Revenue / Share (TTM)$3.22

ROE (TTM)-60.52%

52-Week Low$5.93

vGradeB

gGradeD

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-1.25est. -1.51

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.10

4.09

4.10

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
DRIODarioHealth Corp. Common Stock	B	D	D	$7.50
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

DarioHealth Corp is a digital therapeutics company that delivers personalized interventions for chronic conditions including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The platform combines data analytics, software, and personalized coaching to drive patient engagement and clinical outcomes.